Level of expression of IL-13Rα2 impacts receptor distribution and IL-13 signaling

被引:55
作者
Daines, Michael O. [1 ]
Tabata, Yasuhiro [1 ]
Walker, Bradley A. [1 ]
Chen, Weiguo [1 ]
Warrier, Manoj R. [1 ]
Basu, Saswata [1 ]
Hershey, Gurjit K. Khurana [1 ]
机构
[1] Childrens Hosp, Med Ctr, Div Allergy & Immunol, Dept Pediat, Cincinnati, OH 45229 USA
关键词
D O I
10.4049/jimmunol.176.12.7495
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-13, a critical cytokine for allergic inflammation, exerts its effects through a complex receptor system including IL-4R alpha, IL-13R alpha 1, and IL-13R alpha 2. IL-4R alpha and IL-13R alpha 1 form a heterodimeric signaling receptor for IL-13. In contrast, IL-13Ra2 binds IL-13 with high affinity but does not signal. IL-13R alpha 2 exists on the cell surface, intracellularly, and in soluble form, but no information is available regarding the relative distributions of IL-13R alpha 2 among these compartments, whether the compartments communicate, and how the relative expression levels impact IL-13 responses. Herein, we investigated the distribution of IL-13R alpha 2 in transfected and primary cells, and we evaluated how the total level of IL-13Ra2 expression impacted its distribution. Our results demonstrate that the distribution of IL-13R alpha 2 is independent of the overall level of expression. The majority of the IL-13R alpha 2 protein existed in intracellular pools. Surface IL-13R alpha 2 was continually released into the medium in a soluble form, yet surface expression remained constant supporting receptor trafficking to the cell surface. IL-13Ra2 inhibited IL-13 signaling proportionally to its level of expression, and this inhibition could be overcome with high concentrations of IL-13.
引用
收藏
页码:7495 / 7501
页数:7
相关论文
共 26 条
[1]   Localization of human interleukin 13 receptor in non-haematopoietic cells [J].
Akaiwa, M ;
Yu, B ;
Umeshita-Suyama, R ;
Terada, N ;
Suto, H ;
Koga, T ;
Arima, K ;
Matsushita, S ;
Saito, H ;
Ogawa, H ;
Furue, M ;
Hamasaki, N ;
Ohshima, K ;
Izuhara, K .
CYTOKINE, 2001, 13 (02) :75-84
[2]   cDNA cloning and characterization of the human interleukin 13 receptor alpha chain [J].
Aman, MJ ;
Tayebi, N ;
Obiri, NI ;
Puri, RK ;
Modi, WS ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29265-29270
[3]   Analysis of the life cycle of Stat6 - Continuous cycling of Stat6 is required for IL-4 signaling [J].
Andrews, RP ;
Ericksen, MB ;
Cunningham, CM ;
Daines, MO ;
Hershey, GKK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :36563-36569
[4]   Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain [J].
Caput, D ;
Laurent, P ;
Kaghad, M ;
Lelias, JM ;
Lefort, S ;
Vita, N ;
Ferrara, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16921-16926
[5]  
Chiaramonte MG, 1999, J IMMUNOL, V162, P920
[6]   A novel mechanism by which interferon-γ can regulate interleukin (IL)-13 responses -: Evidence for intracellular stores of IL-13 receptor α-2 and their rapid mobilization by interferon-γ [J].
Daines, MO ;
Hershey, GKK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :10387-10393
[7]   Induction of the IL-13 receptor α2-chain by IL-4 and IL-13 in human keratinocytes:: involvement of STAT6, ERK and p38 MAPK pathways [J].
David, M ;
Ford, D ;
Bertoglio, J ;
Maizel, AL ;
Pierre, J .
ONCOGENE, 2001, 20 (46) :6660-6668
[8]   Erythromelalgia [J].
Mark D. P. Davis ;
Thom Rooke .
Current Treatment Options in Cardiovascular Medicine, 2002, 4 (3) :207-222
[9]  
Donaldson DD, 1998, J IMMUNOL, V161, P2317
[10]   A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor [J].
Gauchat, JF ;
Schlagenhauf, E ;
Feng, NP ;
Moser, R ;
Yamage, M ;
Jeannin, P ;
Alouani, S ;
Elson, G ;
Notarangelo, LD ;
Wells, T ;
Eugster, HP ;
Bonnefoy, JY .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :971-978